Haoyu Chen

Prof. Haoyu Chen

Shantou University, Shantou, Guangdong, China
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 November 2006 in Science
Verified
Journal Article
Closed access
PDF file
ZYZhenglin Yang
Zhenglin Yang
NCNicola J. Camp
Nicola J. Camp
HSHui Sun
Hui Sun
ZTZongzhong Tong
Zongzhong Tong
DGDaniel Gibbs
Daniel Gibbs
KZKang Zhang
Kang Zhang
Age-related macular degeneration (AMD) is the most common cause of irreversible vision loss in the developed world and has a strong genetic predisposition. A locus at human chromosome 10q26 affects the risk of AMD, but the precise gene(s) have not been identified. We genotyped 581 AMD cases and 309 normal controls in a Caucasian cohort in Utah. We demonstrate that a single-nucleotide polymorphism, rs11200638, in the promoter region of HTRA1 is the most likely causal variant for AMD at 10q26 and is estimated to confer a population attributable risk of 49.3%. The HTRA1 gene encodes a secreted serine protease. Preliminary analysis of lymphocytes and retinal pigment epithelium from four AMD patients revealed that the risk allele was associated with elevated expression levels of HTRA1 mRNA and protein. We also found that drusen in the eyes of AMD patients were strongly immunolabeled with HTRA1 antibody. Together, these findings support a key role for HTRA1 in AMD susceptibility and identify a potential new pathway for AMD pathogenesis.

16 March 2008 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
CJChristopher A Jones
Christopher A Jones
NLNyall R London
Nyall R London
HCHaoyu Chen
Haoyu Chen
KPKye won Park
Kye won Park
DSDominique Sauvaget
Dominique Sauvaget
DLDean Y Li
Dean Y Li

12 March 2020 in Eurosurveillance
Verified
Journal Article
Open access
CLCuilian Li
Cuilian Li
LCLi Jia Chen
Li Jia Chen
XCXueyu Chen
Xueyu Chen
MZMingzhi Zhang
Mingzhi Zhang
CPChi Pui Pang
Chi Pui Pang
HCHaoyu Chen
Haoyu Chen
The peak of Internet searches and social media data about the coronavirus disease 2019 (COVID-19) outbreak occurred 10–14 days earlier than the peak of daily incidences in China. Internet searches and social media data had high correlation with daily incidences, with the maximum r > 0.89 in all correlations. The lag correlations also showed a maximum correlation at 8–12 days for laboratory-confirmed cases and 6–8 days for suspected cases.

18 October 2009 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
CJChristopher A. Jones
Christopher A. Jones
NNNaoyuki Nishiya
Naoyuki Nishiya
NLNyall R. London
Nyall R. London
WZWeiquan Zhu
Weiquan Zhu
LSLise K. Sorensen
Lise K. Sorensen
DLDean Y. Li
Dean Y. Li

1 July 2008 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
ZYZhenglin Yang
Zhenglin Yang
YCYali Chen
Yali Chen
Conchi LilloConchi Lillo
Conchi Lillo
JCJeremy Chien
Jeremy Chien
ZYZhengya Yu
Zhengya Yu
KZKang Zhang
Kang Zhang
Familial macular degeneration is a clinically and genetically heterogeneous group of disorders characterized by progressive central vision loss. Here we show that an R373C missense mutation in the prominin 1 gene (PROM1) causes 3 forms of autosomal-dominant macular degeneration. In transgenic mice expressing R373C mutant human PROM1, both mutant and endogenous PROM1 were found throughout the layers of the photoreceptors, rather than at the base of the photoreceptor outer segments, where PROM1 is normally localized. Moreover, the outer segment disk membranes were greatly overgrown and misoriented, indicating defective disk morphogenesis. Immunoprecipitation studies showed that PROM1 interacted with protocadherin 21 (PCDH21), a photoreceptor-specific cadherin, and with actin filaments, both of which play critical roles in disk membrane morphogenesis. Collectively, our results identify what we believe to be a novel complex involved in photoreceptor disk morphogenesis and indicate a possible role for PROM1 and PCDH21 in macular degeneration.

2 October 2008 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
ZYZhenglin Yang
Zhenglin Yang
CSCharity Stratton
Charity Stratton
PFPeter J. Francis
Peter J. Francis
MKMark E. Kleinman
Mark E. Kleinman
PTPerciliz L. Tan
Perciliz L. Tan
KZKang Zhang
Kang Zhang
Age-related macular degeneration is the most common cause of irreversible visual impairment in the developed world. Advanced age-related macular degeneration consists of geographic atrophy and choroidal neovascularization. The specific genetic variants that predispose patients to geographic atrophy are largely unknown. We tested for an association between the functional toll-like receptor 3 gene (TLR3) variant rs3775291 (involving the substitution of phenylalanine for leucine at amino acid 412) and age-related macular degeneration in Americans of European descent. We also tested for the effect of TLR3 Leu and Phe variants on the viability of human retinal pigment epithelial cells in vitro and on apoptosis of retinal pigment epithelial cells from wild-type mice and Tlr3-knockout (Tlr3 −/−) mice. The Phe variant (encoded by the T allele at rs3775291) was associated with protection against geographic atrophy (P=0.005). This association was replicated in two independent case–control series of geographic atrophy (P=5.43×10−4 and P=0.002). No association was found between TLR3 variants and choroidal neovascularization. A prototypic TLR3 ligand induced apoptosis in a greater fraction of human retinal pigment epithelial cells with the Leu–Leu genotype than those with the Leu–Phe genotype and in a greater fraction of wild-type mice than Tlr3 –/– mice. The TLR3 412Phe variant confers protection against geographic atrophy, probably by suppressing the death of retinal pigment epithelial cells. Since double-stranded RNA (dsRNA) can activate TLR3-mediated apoptosis, our results suggest a role of viral dsRNA in the development of geographic atrophy and point to the potential toxic effects of short-interfering-RNA therapies in the eye.